- Home
- COYA vs MDBH Comparison
COYA vs MDBH Comparison
Compare COYA & MDBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COYA
- MDBH
- Stock Information
- Founded
- COYA 2020
- MDBH 1997
- Country
- COYA United States
- MDBH United States
- Employees
- COYA N/A
- MDBH N/A
- Industry
- COYA Biotechnology: Pharmaceutical Preparations
- MDBH
- Sector
- COYA Health Care
- MDBH
- Exchange
- COYA Nasdaq
- MDBH Nasdaq
- Market Cap
- COYA 92.1M
- MDBH 99.2M
- IPO Year
- COYA 2022
- MDBH 2023
- Fundamental
- Price
- COYA $6.01
- MDBH $8.10
- Analyst Decision
- COYA Strong Buy
- MDBH
- Analyst Count
- COYA 2
- MDBH 0
- Target Price
- COYA $16.00
- MDBH N/A
- AVG Volume (30 Days)
- COYA 47.4K
- MDBH 6.6K
- Earning Date
- COYA 08-12-2024
- MDBH 08-13-2024
- Dividend Yield
- COYA N/A
- MDBH N/A
- EPS Growth
- COYA N/A
- MDBH N/A
- EPS
- COYA N/A
- MDBH N/A
- Revenue
- COYA $9,554,315.00
- MDBH $1,776,726.00
- Revenue This Year
- COYA N/A
- MDBH N/A
- Revenue Next Year
- COYA $76.77
- MDBH N/A
- P/E Ratio
- COYA N/A
- MDBH N/A
- Revenue Growth
- COYA N/A
- MDBH N/A
- 52 Week Low
- COYA $3.21
- MDBH $7.00
- 52 Week High
- COYA $10.69
- MDBH $21.67
- Technical
- Relative Strength Index (RSI)
- COYA 49.21
- MDBH 39.10
- Support Level
- COYA $5.72
- MDBH $7.66
- Resistance Level
- COYA $6.22
- MDBH $8.10
- Average True Range (ATR)
- COYA 0.39
- MDBH 0.44
- MACD
- COYA 0.07
- MDBH -0.10
- Stochastic Oscillator
- COYA 73.95
- MDBH 22.60
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
About MDBH MDB Capital Holdings LLC common
MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.